Varying doses of evening caffeine ingestion have different effects on rowing ergometer performance, sleep quality, and wakefulness scores
Yazarlar (11)
Prof. Dr. İzzet Karakulak Mardin Artuklu Üniversitesi, Türkiye
Doç. Dr. Ulaş Can YILDIRIM Sinop Üniversitesi, Türkiye
Dilara Erkan
Ankara Üniversitesi, Türkiye
Dr. Öğr. Üyesi Raci Karayiğit Ankara Üniversitesi, Türkiye
Doç. Dr. Ender Eyuboğlu Bartın Üniversitesi, Türkiye
Dr. Öğr. Üyesi Azize Bingöl Dıedhıou Şırnak Üniversitesi, Türkiye
Arş. Gör. Mehmet Can GÜNDEM Sinop Üniversitesi, Türkiye
Doç. Dr. Damla Selin Yıldırım Lokman Hekim Üniversitesi, Türkiye
Dr. Öğr. Üyesi Halit ŞAR Sinop Üniversitesi, Türkiye
Doç. Dr. Gökmen Özen Çanakkale Onsekiz Mart Üniversitesi, Türkiye
Prof. Dr. Fırat Akça Ankara Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Frontiers in Nutrition (Q1)
Dergi ISSN 2296-861X Dergi Bilgileri (2025)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 12-2025
Cilt / Sayı / Sayfa 12 / 1 / 1659220–0 DOI 10.3389/fnut.2025.1659220
Makale Linki https://doi.org/10.3389/fnut.2025.1659220
UAK Araştırma Alanları
Ergojenik Yardım ve Doping Antrenman Bilimi
Özet
Introduction This study investigated the dose-dependent effects of evening caffeine ingestion on rowing performance, sleep quality, and daytime sleepiness in trained male rowers. Methods Using a double-blind, randomized, crossover design, 13 university-level rowers (mean age = 22.07 ± 2.21 years; mean body mass = 77.66 ± 6.45 kg) completed four 2,000 m time–trial sessions between 19:00 and 20:00 h under placebo (PLA), low-dose capsule caffeine (3 mg/kg, LDC), moderate-dose capsule caffeine (6 mg/kg, MDC), and high-dose capsule caffeine (9 mg/kg, HDC) conditions. Performance metrics, heart rate, and subjective sleep assessments were collected. Rowing performance was assessed by a standard 2,000 m rowing ergometer (Concept II, United States) time trial. Sleep quality was measured with a numerical rating scale in the morning after each trial, and daytime sleepiness was measured with the Karolinska Sleepiness Scale. Results Results indicated significantly improved rowing times and power output with HDC and MDC compared to PLA (p < 0.05), with HDC yielding the most notable enhancements (d = 0.40–0.41). However, these ergogenic benefits were accompanied by significantly impaired sleep quality and elevated daytime sleepiness in both HDC and MDC groups (p < 0.01; d = 1.3–1.5). Notably, adverse effects such as headache, insomnia, and gastrointestinal discomfort were predominantly reported in the HDC condition (p < 0.05). Although LDC offered mild performance improvements with minimal sleep disruption, only the high dose condition exhibited large physiological and perceptual trade-offs. Discussion …
Anahtar Kelimeler
caffeine | dose-response | rowing performance | sleep quality | wakefulness